EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery

Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Abdullah Altaf, Jun Kawashima, Khalid Mumtaz, Timothy M Pawlik iD

World Journal of Surgery · 2025-03 · 49 (3) · 698-707

DOI: 10.1002/wjs.12484 ↗

At a glance

Journal article in World Journal of Surgery, published online on 2025-01-09. Written by Zayed Rashid and 6 co-authors. Institution: Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA. Major MEDLINE topics: Postoperative Complications, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents, Preoperative Care. Cited 20 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are increasingly being used for the management of diabetes mellitus and obesity. We sought to define the impact of preoperative GLP‐1RA use on outcomes following major surgical procedures.

Methods

Patients who underwent a major surgical procedure between 2013 and 2021 were identified using the IBM MarketScan database. Patients who took GLP‐1RA within a year before surgery were categorized as “exposed.” After propensity score matching (PSM), multivariable regression analysis was used to define the association of GLP‐1RA exposure with postoperative complications.

Results

Among 138,980 patients (coronary artery bypass graft: n = 39,516, 28.4%; pneumonectomy: n = 4,881, 3.5%; abdominal aortic aneurysm repair: 4,459, 3.3%; pancreatectomy: n = 15,873, 11.4%; and colectomy: n = 74,251, 53.4%), most individuals were male ( n = 80,871, 58.2%) with a median age of 58 (IQR 53–61) years. 2944 (2.2%) individuals had GLP‐1RA exposure before surgery. Overall incidence of complications was 36.5% ( n = 50,724); complications included sepsis ( n = 6,385, 4.6%), surgical site infections ( n = 7,431, 5.3%), thromboembolism ( n = 3,609, 2.6%), pneumonia ( n = 4,783, 3.4%), renal ( n = 9,017, 6.5%), or cardiopulmonary failure ( n = 26,661, 19.2%). On unmatched analysis, patients on GLP‐1RA had a higher risk of complications (no GLP‐1RA: 36.3% vs. GLP‐1RA: 44.5% p < 0.001); however, after PSM to account for measured confounders, GLP‐1RA exposure was not associated with the odds of surgical complications (OR 0.99 95% CI 0.91–1.08; p > 0.05). Among patients using GLP‐1RA during the 2 weeks before surgery ( n = 522, 17.7%), there was no association of GLP‐1RA with risk of complications (nonrecent GLP‐1RA: 44.7% vs. recent GLP‐1RA: 44.1%; p = 0.992).

Conclusions

GLP‐1RA use was not associated with an increased risk of complications following major surgical procedures.

Subjects

MeSH terms (MEDLINE)

Postoperative ComplicationsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsPreoperative CareSurgical Procedures, OperativeHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPropensity ScoreTreatment Outcome

Author keywords

GLP‐1RAMarketScanileusmajor surgical proceduressurgical complications

Substances

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Authors and institutions

  • Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Department of Internal Medicine, Division of Palliative Care, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.

ORCID profiles: Timothy M Pawlik

Cite

APA

Rashid, Z., Woldesenbet, S., Khalil, M., Altaf, A., Kawashima, J., Mumtaz, K., & Pawlik, T. M. (2025). Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery. World Journal of Surgery, 49(3), 698-707. https://doi.org/10.1002/wjs.12484

Vancouver

Rashid Z, Woldesenbet S, Khalil M, Altaf A, Kawashima J, Mumtaz K, et al. Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery. World Journal of Surgery. 2025;49(3):698-707. doi:10.1002/wjs.12484

BibTeX
@article{Rashid2025,
  author = {Rashid, Zayed and Woldesenbet, Selamawit and Khalil, Mujtaba and Altaf, Abdullah and Kawashima, Jun and Mumtaz, Khalid and Pawlik, Timothy M},
  title = {Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery},
  journal = {World Journal of Surgery},
  year = {2025},
  volume = {49},
  number = {3},
  pages = {698--707},
  doi = {10.1002/wjs.12484}
}
Start for free →